Physician profile
Kevin Karl Kruse
NPI 1508094137
$173,997.33
in general payments reported to CMS, 2019-2025
17 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89K · 2020: $31K · 2021: $38K · 2022: $124 · 2023: $2,405 · 2024: $2,010 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $3,060 · Gift: $15.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,954.09 |
| Food and Beverage | $3,060.06 |
| Gift | $15.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $113,361.51 | 2019-2024 | Arthrex |
| Wright Medical Technology, INC. | $38,486.04 | 2019-2020 | |
| Zurimed Technologies INC. | $11,330.88 | 2025 | Fiberlocker System |
| Pylant Medical | $5,644.18 | 2019-2021 | |
| Stryker Corporation | $2,662.70 | 2019-2025 | Blueprint Patient Specific Instrumentation, Reunion |
| Shoulder Innovations, INC. | $1,918.90 | 2024-2025 | Inset System |
| Zimmer Biomet Holdings, INC. | $148.44 | 2019-2022 | |
| Depuy Synthes Sales INC. | $107.19 | 2022-2025 | Monovisc, Orthovisc |
| Smith+Nephew, INC. | $97.96 | 2020-2024 | N/A, Ascension, Safeguard |
| Encore Medical, Lp | $71.98 | 2019 | |
| Bioventus LLC | $46.61 | 2025 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $26.72 | 2020 | |
| Axogen | $25.28 | 2023 | Avance Nerve Graft |
| Orthofix Medical, INC. | $22.22 | 2023 | Physio-Stim |
| Cumberland Pharmaceuticals, INC. | $18.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $14.80 | 2021 | |
| Medline Industries Lp | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,132,803.65 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kruse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.